No Data
No Data
Big Pharma's Stability in Return on R&D Investment Is Encouraging -- Market Talk
Is Novo Nordisk A/S (NVO) A Good Biotech Stock to Buy?
Why Big Pharma Is Betting on Telehealth Strategies
Novo Nordisk to Present New Data From Key Diabetes and Obesity Trials at the 60th Annual Meeting of the European Association for the Study of Diabetes
Who Can Use the New Obesity Drugs? Nearly Half of Adults Under 65 Are Eligible. -- Barrons.com
Eli Lilly Makes Strides on Weekly Insulin Shot as Novo Nordisk Stumbles
No Data
MonkeyGee : if you need a pill to lose weight, you have other issues.
Learning_Piggy : I used to think this way until I looked around and see more than a few obese people never managed to get out of obesity by themselves.
With or without surgery, with or without dietary restriction, obesity will most likely come back to them and it takes more than just personal grit to fight it.
InfiltradeR Learning_Piggy : Let's not forget the ever rising diabetes numbers.
Learning_Piggy InfiltradeR : exactly!